Send to

Choose Destination
Food Sci Biotechnol. 2018 Jan 23;27(4):1185-1192. doi: 10.1007/s10068-018-0322-4. eCollection 2018 Aug.

Effect of oral administration of β-glucans derived from Aureobasidium pullulans SM-2001 in model mice and rat with atopic dermatitis-like phenotypes.

Author information

1Department of Animal Resources Technology, Gyeongnam National University of Science and Technology, Jinju, 52725 Korea.
2Department of Nano-Bioengineering, Incheon National University, Incheon, 22012 Korea.
3Swine Science and Technology Center, Gyeongnam National University of Science and Technology, Jinju, 52725 Korea.
Glucan Corporation, Busan, 46048 Korea.
5Department of Animal Science and Technology, Sunchon National University, Suncheon, 57922 Korea.
6Department of Agricultural Biotechnology, Seoul National University, Seoul, 08826 Korea.
7Departmnet of Life Science, Silla University, Busan, 46958 Korea.


In this study, we investigated the anti-atopic dermatitis (AD) activity of β-glucans derived from Aureobasidium pullulans SM-2001 (βGdAP). βGdAP was orally administered to AD animal models such as vasodilation, allergic pruritus and contact dermatitis. Administration of βGdAP attenuated the amount of Evans blue solution on vasodilation rat. Scratching behaviors, secretion of histamine and ear thickness were significantly (p < 0.05) attenuated in the βGdAP-treated mouse groups. Interestingly, transcriptional expression of T-bet, a transcription factor for Th1 reactions, was increased, but that of GATA-3, a transcription factor for Th2 reactions, was attenuated in the βGdAP-treated groups (p < 0.05). In addition, we found that reduced transcriptional expression of forkhead box P3 and galectin-9, regulators of regulatory T cells, was recovered in the βGdAP-treated groups (p < 0.05). Taken together, these data indicate that administration of βGdAP could effectively attenuate AD-like phenotypes via regulation of Th1/Th2 transcriptional activity and Treg activation.


Atopic dermatitis; Aureobasidium pullulans SM-2001; FOXP3; Galectin-9; Th1/Th2; β-Glucan

Conflict of interest statement

Compliance with ethical standardsWe certify that there is no conflict of interest in the manuscript.

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center